Go Pro
→ PH: Do THESE 4 things to your bank account now … (From Weiss Ratings) (Ad)tc pixel Free FENC Stock Alerts

Adherex Technologies (FENC) Financials

Adherex Technologies logo
$10.70 0.00 (0.00%)
Closing price 07/2/2026 04:00 PM Eastern
Extended Trading
$10.54 -0.16 (-1.54%)
As of 07/2/2026 05:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Adherex Technologies

Annual Income Statements for Adherex Technologies

This table shows Adherex Technologies' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -0.66 -2.79 -7.05 -9.89 -13 -18 -17 -24 -16 -0.44 -9.74
Consolidated Net Income / (Loss)		 -0.66 -2.79 -7.05 -9.89 -13 -18 -17 -24 -16 -0.44 -9.74
Net Income / (Loss) Continuing Operations		 -0.66 -2.79 -7.05 -9.89 -13 -18 -17 -24 -16 -0.44 -9.74
Total Pre-Tax Income 		-0.66 -2.79 -7.05 -9.89 -13 -18 -17 -24 -16 -0.07 -9.64
Total Operating Income		 -1.89 -2.87 -6.95 -10 -13 -18 -17 -23 -13 2.57 -6.28
Total Gross Profit		 0.00 0.00 0.00 0.00 0.00 0.17 0.00 1.45 20 44 41
Total Revenue		 0.00 0.00 0.00 0.00 0.00 0.17 0.00 1.54 21 48 45
Operating Revenue		 0.00 0.00 0.00 0.00 0.00 0.17 0.00 1.54 21 48 45
Total Cost of Revenue		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.09 1.26 3.18 3.76
Operating Cost of Revenue		 - - - - - - 0.00 0.09 1.26 3.18 3.76
Total Operating Expenses		 1.89 2.87 6.95 10 13 18 17 24 33 42 47
Selling, General & Admin Expense		 1.63 2.40 5.02 5.40 7.40 13 12 18 21 23 28
Marketing Expense		 - - - - - - 0.00 2.79 12 18 19
Research & Development Expense		 0.26 0.47 1.94 5.01 5.61 5.11 4.98 3.53 0.06 0.31 0.25
Total Other Income / (Expense), net		 1.23 0.08 -0.10 0.52 0.23 -0.22 -0.12 -0.94 -3.27 -2.64 -3.35
Interest Expense		 - - - - - 0.41 0.14 0.93 3.68 4.16 4.17
Interest & Investment Income		 0.00 0.01 0.05 0.35 0.32 0.09 0.05 - 0.44 1.68 0.79
Other Income / (Expense), net		 1.23 0.07 -0.14 0.17 -0.08 0.10 -0.04 -0.01 -0.03 -0.16 0.03
Income Tax Expense		 - - - - - - - - 0.00 0.37 0.11
Basic Earnings per Share		 ($0.06) ($0.22) ($0.47) ($0.52) ($0.64) ($0.76) ($0.67) ($0.90) ($0.60) ($0.02) ($0.34)
Weighted Average Basic Shares Outstanding		 10.83M 12.77M 15.01M 18.94M 19.90M 23.70M 26.01M 26.28M 26.57M 27.29M 28.58M
Diluted Earnings per Share		 ($0.06) ($0.22) ($0.47) ($0.52) ($0.64) ($0.76) ($0.67) ($0.90) ($0.60) ($0.02) ($0.34)
Weighted Average Diluted Shares Outstanding		 10.83M 12.77M 15.01M 18.94M 19.90M 23.70M 26.01M 26.28M 26.57M 27.29M 28.58M
Weighted Average Basic & Diluted Shares Outstanding		 10.83M 12.77M 15.01M 18.94M 19.90M 23.70M 26.01M 26.41M 27.10M 27.59M 34.48M

Quarterly Income Statements for Adherex Technologies

This table shows Adherex Technologies' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -1.87 -2.68 13 -5.55 -5.74 -1.99 -1.17 -3.15 -0.64 -4.79 0.20
Consolidated Net Income / (Loss)		 -1.87 -2.68 13 -5.55 -5.74 -1.99 -1.17 -3.15 -0.64 -4.79 0.20
Net Income / (Loss) Continuing Operations		 -1.87 -2.68 13 -5.55 -5.74 -1.99 -1.17 -3.15 -0.64 -4.79 0.20
Total Pre-Tax Income 		-1.87 -2.68 13 -5.55 -5.74 -1.62 0.00 -3.15 -0.64 -4.68 0.00
Total Operating Income		 -1.02 -1.82 14 -5.04 -5.20 -0.93 -0.81 -2.73 -0.19 -2.55 -0.12
Total Gross Profit		 6.18 9.05 25 6.65 5.62 7.26 8.38 8.69 12 12 15
Total Revenue		 6.52 9.74 25 7.26 6.97 7.93 8.75 9.65 12 14 15
Operating Revenue		 6.52 9.74 25 7.26 6.97 7.93 8.75 9.65 12 14 15
Total Cost of Revenue		 0.33 0.69 0.55 0.61 1.36 0.67 0.37 0.97 0.66 1.76 0.57
Operating Cost of Revenue		 0.33 0.69 0.55 0.61 1.36 0.67 0.37 0.97 0.66 1.76 0.57
Total Operating Expenses		 7.20 11 11 12 11 8.19 9.19 11 12 15 15
Selling, General & Admin Expense		 3.81 6.97 5.87 6.86 6.12 4.20 5.87 6.96 6.75 8.44 3.19
Marketing Expense		 3.38 3.87 5.21 4.67 4.60 3.94 3.23 4.35 5.21 6.11 11
Research & Development Expense		 0.01 0.03 0.00 0.16 0.10 0.05 0.09 0.11 0.03 0.02 0.05
Total Other Income / (Expense), net		 -0.85 -0.86 -0.91 -0.51 -0.53 -0.69 -0.36 -0.42 -0.45 -2.13 0.32
Interest Expense		 0.93 1.21 1.05 1.07 1.05 1.76 0.61 0.61 0.60 2.36 0.01
Interest & Investment Income		 0.10 - 0.20 0.57 0.52 - 0.24 0.17 0.15 0.23 0.34
Other Income / (Expense), net		 -0.02 0.01 -0.05 -0.02 -0.00 -0.09 0.01 0.02 -0.00 0.00 -0.01
Basic Earnings per Share		 ($0.07) ($0.09) $0.47 ($0.20) ($0.21) ($0.02) ($0.04) ($0.11) ($0.02) ($0.17) $0.01
Weighted Average Basic Shares Outstanding		 26.60M 26.57M 27.05M 27.30M 27.37M 27.29M 27.58M 27.66M 27.89M 28.58M 34.34M
Diluted Earnings per Share		 ($0.07) ($0.09) $0.41 ($0.20) ($0.21) ($0.02) ($0.04) ($0.11) ($0.02) ($0.17) $0.01
Weighted Average Diluted Shares Outstanding		 26.60M 26.57M 31.09M 27.30M 27.37M 27.29M 27.58M 27.66M 27.89M 28.58M 35.55M
Weighted Average Basic & Diluted Shares Outstanding		 26.63M 27.10M 27.32M 27.36M 27.43M 27.59M 27.62M 27.83M 28.12M 34.48M 34.74M

Annual Cash Flow Statements for Adherex Technologies

This table details how cash moves in and out of Adherex Technologies' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -1.37 2.98 24 -5.48 -9.13 17 -9.24 2.67 -11 13 10
Net Cash From Operating Activities		 -1.86 -2.12 -3.64 -7.83 -9.06 -16 -14 -18 -17 27 -12
Net Cash From Continuing Operating Activities		 -1.86 -2.12 -3.64 -7.83 -9.06 -16 -14 -18 -17 27 -12
Net Income / (Loss) Continuing Operations		 -0.66 -2.79 -7.05 -9.89 -13 -18 -17 -24 -16 -0.44 -9.74
Consolidated Net Income / (Loss)		 -0.66 -2.79 -7.05 -9.89 -13 -18 -17 -24 -16 -0.44 -9.74
Amortization Expense		 - - - 0.00 0.06 0.40 0.02 0.15 0.29 0.96 0.17
Non-Cash Adjustments To Reconcile Net Income		 0.10 0.70 2.26 2.10 3.08 2.78 4.04 4.40 5.39 9.51 12
Changes in Operating Assets and Liabilities, net		 -1.30 -0.04 1.15 -0.04 0.57 -0.66 -0.93 1.10 -6.78 17 -15
Net Cash From Investing Activities		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Cash From Continuing Investing Activities		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Cash From Financing Activities		 0.50 5.11 28 2.35 -0.07 32 4.98 21 6.64 -14 23
Net Cash From Continuing Financing Activities		 0.50 5.11 28 2.35 -0.07 32 4.99 21 6.64 -14 23
Repayment of Debt		 - - - - - 0.00 0.00 -4.94 0.00 -15 -21
Other Financing Activities, net		 0.50 0.11 0.59 2.35 0.00 0.46 0.03 0.73 1.64 1.13 44
Cash Interest Paid		 - - - - - - - - - 3.82 4.16
Cash Income Taxes Paid		 - - - - - - - - - 0.00 0.75

Quarterly Cash Flow Statements for Adherex Technologies

This table details how cash moves in and out of Adherex Technologies' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -2.56 0.87 38 -8.13 -2.73 -14 -3.96 -3.97 3.24 15 3.39
Net Cash From Operating Activities		 -2.76 -4.86 39 -8.39 -2.21 -1.47 -4.32 -3.69 1.49 -5.96 2.38
Net Cash From Continuing Operating Activities		 -2.76 -4.86 39 -8.39 -2.21 -1.47 -4.32 -3.69 1.49 -5.96 2.38
Net Income / (Loss) Continuing Operations		 -1.87 -2.68 13 -5.55 -5.74 -1.99 -1.17 -3.15 -0.64 -4.79 0.20
Consolidated Net Income / (Loss)		 -1.87 -2.68 13 -5.55 -5.74 -1.99 -1.17 -3.15 -0.64 -4.79 0.20
Amortization Expense		 0.07 0.07 0.74 0.05 0.05 -0.68 0.04 -0.01 0.01 0.13 0.03
Non-Cash Adjustments To Reconcile Net Income		 1.56 0.18 1.60 1.33 6.25 1.14 0.88 2.69 0.57 7.79 0.94
Changes in Operating Assets and Liabilities, net		 -2.52 -2.42 24 -4.21 -2.76 0.05 -4.07 -3.21 1.55 -9.10 1.22
Net Cash From Investing Activities		 - - 0.00 - - - 0.00 - - - 0.00
Net Cash From Continuing Investing Activities		 - - 0.00 - - - 0.00 - - - 0.00
Net Cash From Financing Activities		 0.20 5.73 -1.13 0.26 -0.53 -12 0.36 -0.28 1.75 21 1.01
Net Cash From Continuing Financing Activities		 0.20 5.73 -1.13 0.26 -0.53 -12 0.36 -0.28 1.75 21 1.01
Other Financing Activities, net		 0.20 0.73 0.61 0.26 -0.53 0.79 0.36 -0.28 1.75 42 1.01

Annual Balance Sheets for Adherex Technologies

This table presents Adherex Technologies' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 1.02 3.97 28 23 14 31 22 27 27 45 71
Total Current Assets		 1.02 3.97 28 23 14 31 22 27 27 44 67
Cash & Equivalents		 0.94 3.93 28 23 14 30 21 24 13 27 37
Accounts Receivable		 - - - - - - - 1.55 8.81 13 23
Inventories, net		 - - - - - - 0.00 0.58 2.16 1.06 1.57
Prepaid Expenses		 0.08 0.04 0.13 0.17 0.23 0.80 1.03 0.77 2.58 3.08 3.74
Other Current Assets		 0.00 0.00 0.01 0.00 0.01 0.28 0.25 0.06 0.04 0.47 1.73
Plant, Property, & Equipment, net		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Noncurrent Assets		 0.00 0.00 0.00 0.00 0.26 0.00 0.00 0.21 0.01 0.82 3.51
Noncurrent Note & Lease Receivables		 - - - - - - - - - 0.00 2.79
Other Noncurrent Operating Assets		 - - - 0.00 0.26 - - 0.21 0.01 0.82 0.72
Total Liabilities & Shareholders' Equity		 1.02 3.97 28 23 14 31 22 27 27 45 71
Total Liabilities		 0.47 0.40 1.64 1.64 2.27 2.35 6.64 30 38 51 35
Total Current Liabilities		 0.47 0.40 1.64 1.64 2.27 2.35 1.65 4.61 7.55 6.92 11
Accounts Payable		 0.30 0.24 0.86 1.03 1.61 1.57 0.78 2.39 3.78 3.24 4.64
Accrued Expenses		 0.09 0.13 0.62 0.61 0.66 0.78 0.88 2.22 3.75 3.43 5.64
Other Current Liabilities		 0.08 0.03 0.17 - - - - 0.00 0.02 0.00 0.25
Total Noncurrent Liabilities		 0.00 0.00 0.00 0.00 0.00 0.00 4.99 25 31 44 25
Other Noncurrent Operating Liabilities		 - - - - - 0.00 - 25 31 19 25
Total Equity & Noncontrolling Interests		 0.55 3.57 27 21 12 29 16 -2.57 -12 -5.87 35
Total Preferred & Common Equity		 0.55 3.57 27 21 12 29 16 -2.57 -12 -5.87 35
Total Common Equity		 0.55 3.57 27 21 12 29 16 -2.57 -12 -5.87 35
Common Stock		 111 117 147 151 155 190 194 199 206 213 264
Retained Earnings		 -112 -114 -121 -131 -144 -162 -179 -203 -219 -220 -229
Accumulated Other Comprehensive Income / (Loss)		 1.24 1.24 1.24 1.24 1.24 1.24 1.24 1.24 1.24 1.24 1.24

Quarterly Balance Sheets for Adherex Technologies

This table presents Adherex Technologies' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 19 69 63 59 46 45 49 72
Total Current Assets		 19 68 62 58 43 41 46 67
Cash & Equivalents		 12 51 43 40 23 19 22 40
Accounts Receivable		 4.53 10 12 13 15 18 19 19
Inventories, net		 1.76 2.06 2.14 1.13 1.40 2.20 2.48 1.86
Prepaid Expenses		 0.25 4.49 4.38 3.07 2.44 1.42 1.40 3.46
Other Current Assets		 0.02 0.16 0.28 0.55 1.00 0.97 0.90 2.62
Plant, Property, & Equipment, net		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Noncurrent Assets		 0.08 1.02 0.99 0.96 3.43 4.08 3.20 4.94
Noncurrent Note & Lease Receivables		 - - - - 2.63 3.31 2.45 4.25
Other Noncurrent Operating Assets		 0.08 1.02 0.99 0.96 0.79 0.77 0.74 0.69
Total Liabilities & Shareholders' Equity		 19 69 63 59 46 45 49 72
Total Liabilities		 30 66 65 64 52 52 54 34
Total Current Liabilities		 3.91 9.84 7.75 7.44 8.37 8.41 9.82 9.59
Accounts Payable		 2.94 5.20 4.45 3.87 5.28 5.94 5.87 6.28
Accrued Expenses		 0.95 4.36 3.04 3.31 2.84 2.23 3.70 3.06
Other Current Liabilities		 0.02 0.02 0.01 0.01 0.00 0.00 0.00 0.25
Total Noncurrent Liabilities		 26 56 57 57 44 44 44 25
Other Noncurrent Operating Liabilities		 26 32 32 32 19 19 19 25
Total Equity & Noncontrolling Interests		 -11 3.01 -1.36 -5.17 -5.88 -7.46 -4.49 38
Total Preferred & Common Equity		 -11 3.01 -1.36 -5.17 -5.88 -7.46 -4.49 38
Total Common Equity		 -11 3.01 -1.36 -5.17 -5.88 -7.46 -4.49 38
Common Stock		 205 208 209 211 214 215 219 266
Retained Earnings		 -217 -206 -212 -218 -221 -224 -225 -229
Accumulated Other Comprehensive Income / (Loss)		 1.24 1.24 1.24 1.24 1.24 1.24 1.24 1.24

Annual Metrics And Ratios for Adherex Technologies

This table displays calculated financial ratios and metrics derived from Adherex Technologies' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 10,939,226.00 13,642,567.00 15,869,978.00 19,729,164.00 19,895,830.00 25,809,684.00 26,006,853.00 26,237,726.00 26,634,676.00 - 28,116,829.00
DEI Adjusted Shares Outstanding		 10,939,226.00 13,642,567.00 15,869,978.00 19,729,164.00 19,895,830.00 25,809,684.00 26,006,853.00 26,237,726.00 26,634,676.00 - 28,116,829.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.06 -0.20 -0.44 -0.50 -0.64 -0.70 -0.67 -0.90 -0.60 - -0.35
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -100.00% 0.00% 1,284.50% 123.69% -6.09%
EBITDA Growth		 69.61% -322.51% -153.59% -44.31% -27.26% -33.45% 0.81% -30.20% 44.24% 120.48% -280.98%
EBIT Growth		 69.61% -322.51% -153.59% -44.31% -27.88% -35.87% 2.96% -30.94% 43.34% 118.78% -360.12%
NOPAT Growth		 34.31% -51.90% -142.11% -49.75% -24.98% -37.48% 3.70% -31.16% 43.46% 120.11% -344.63%
Net Income Growth		 69.72% -323.22% -152.64% -40.33% -29.20% -41.75% 4.21% -36.71% 32.34% 97.28% -2,134.17%
EPS Growth		 72.73% -266.67% -113.64% -10.64% -23.08% -18.75% 11.84% -34.33% 33.33% 96.67% -1,600.00%
Operating Cash Flow Growth		 -9.59% -14.07% -71.42% -114.94% -15.77% -72.13% 8.80% -26.97% 5.07% 257.38% -146.23%
Free Cash Flow Firm Growth		 23.70% 21.93% -81.60% -96.88% -20.19% -47.97% 0.44% 181.19% -199.43% 188.52% -485.66%
Invested Capital Growth		 76.74% 9.64% -322.19% 2.33% -20.91% 28.23% 71.19% -7,176.29% 5.71% -29.65% 95.97%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -100.00% 0.00% 62.83% -3.67% 15.09%
EBITDA Q/Q Growth		 -152.29% -27.54% -19.71% -8.32% -4.51% 4.51% -9.71% -7.55% 25.12% -0.16% -13.31%
EBIT Q/Q Growth		 -152.29% -27.54% -19.71% -8.32% -4.64% 4.50% -9.76% -7.81% 24.70% 44.88% -32.21%
NOPAT Q/Q Growth		 37.89% -26.14% -24.53% -6.01% -4.40% 1.69% -5.26% -9.33% 25.26% 52.49% -34.72%
Net Income Q/Q Growth		 -151.93% -27.58% -19.44% -7.55% -5.15% 2.01% -7.36% -11.42% 20.65% 61.52% -40.36%
EPS Q/Q Growth		 -142.86% -22.22% -17.50% 0.00% -88.24% 30.28% -9.84% -9.76% 22.08% 77.78% -78.95%
Operating Cash Flow Q/Q Growth		 2.31% -9.65% -24.18% -25.90% 12.88% -12.19% 0.27% -24.53% 10.18% 14.35% -56.21%
Free Cash Flow Firm Q/Q Growth		 53.19% -26.15% -9.55% -21.25% 13.30% -18.46% -60.05% 160.94% -219.73% -60.86% -59.19%
Invested Capital Q/Q Growth		 -13.54% -12.30% -81.08% 11.83% -645.80% 35.69% 93.12% -957.17% -8.40% 28.59% 95.04%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 100.00% 0.00% 94.40% 94.08% 93.30% 91.57%
EBITDA Margin		 0.00% 0.00% 0.00% 0.00% 0.00% -10,225.29% 0.00% -1,462.48% -58.90% 5.39% -13.64%
Operating Margin		 0.00% 0.00% 0.00% 0.00% 0.00% -10,520.59% 0.00% -1,471.60% -60.09% 5.40% -14.07%
EBIT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% -10,461.76% 0.00% -1,472.18% -60.25% 5.06% -14.01%
Profit (Net Income) Margin		 0.00% 0.00% 0.00% 0.00% 0.00% -10,652.35% 0.00% -1,544.89% -75.50% -0.92% -21.82%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.78% 100.00% 614.08% 101.10%
Interest Burden Percent		 99.55% 99.71% 99.34% 96.60% 97.59% 101.82% 100.51% 104.12% 125.30% -2.95% 154.01%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -113.52% -135.45% -46.47% -41.14% -76.99% -88.46% -77.37% -359.22% 226.13% 4.98% -65.82%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% 0.00% 0.00% -78.07% 0.00% -91.58% -47.60% 6.70% -10.83%
Return on Assets (ROA)		 0.00% 0.00% 0.00% 0.00% 0.00% -79.49% 0.00% -96.10% -59.64% -1.21% -16.87%
Return on Common Equity (ROCE)		 -113.52% -135.45% -46.47% -41.14% -76.99% -88.46% -77.37% -359.22% 226.13% 4.98% -65.82%
Return on Equity Simple (ROE_SIMPLE)		 -120.26% -78.12% -26.33% -46.39% -107.58% -62.29% -109.98% 923.08% 138.06% 7.43% 0.00%
Net Operating Profit after Tax (NOPAT)		 -1.32 -2.01 -4.87 -7.29 -9.11 -13 -12 -16 -8.94 1.80 -4.40
NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% -7,364.41% 0.00% -1,030.12% -42.07% 3.78% -9.85%
Net Nonoperating Expense Percent (NNEP)		 40.87% -32.02% -13.55% -10.19% -20.14% -25.41% -22.76% -39.24% -37.70% -11.08% -16.81%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - 75.06% -29.91% -12.40%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 5.60% 5.92% 6.70% 8.43%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 7,617.65% 0.00% 1,154.53% 96.86% 48.49% 63.38%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 3,002.94% 0.00% 230.03% 0.26% 0.65% 0.56%
Operating Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 10,620.59% 0.00% 1,565.99% 154.17% 87.90% 105.64%
Earnings before Interest and Taxes (EBIT)		 -0.66 -2.80 -7.09 -10 -13 -18 -17 -23 -13 2.41 -6.26
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -0.66 -2.80 -7.09 -10 -13 -17 -17 -22 -13 2.56 -6.09
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 17.97 3.44 5.94 5.91 10.87 6.61 7.26 0.00 0.00 0.00 6.10
Price to Tangible Book Value (P/TBV)		 17.97 3.44 5.94 5.91 10.87 6.61 7.26 0.00 0.00 0.00 6.10
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00 0.00 1,131.07 0.00 164.09 14.06 3.65 4.85
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00 0.00 952.58 0.00 148.37 13.42 3.08 4.03
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 57.18 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 60.96 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 81.55 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 5.43 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 21.64 0.00 15.83 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.14 0.02 0.02 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.14 0.02 0.02 0.00
Financial Leverage		 -2.80 -1.18 -1.06 -1.06 -1.10 -1.07 -1.04 -3.05 2.66 2.31 -2.15
Leverage Ratio		 2.92 1.21 1.07 1.07 1.12 1.11 1.20 3.74 -3.79 -4.10 3.90
Compound Leverage Factor		 2.91 1.21 1.06 1.03 1.09 1.13 1.21 3.89 -4.75 0.12 6.01
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 12.32% 2.42% 2.31% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 12.32% 2.42% 2.31% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 87.68% 97.58% 97.69% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.02 -0.05 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.08 1.08 -10.44 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.02 -0.05 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.03 -0.08 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.53 1.52 -14.89 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.03 -0.08 0.00
Altman Z-Score		 -142.19 -23.21 52.36 37.77 17.79 41.18 -2.30 -7.16 -6.69 -2.57 0.45
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.16 9.88 17.28 14.02 6.11 13.39 13.54 5.80 3.56 6.38 6.37
Quick Ratio		 2.00 9.77 17.19 13.92 6.01 12.93 12.76 5.49 2.92 5.71 5.71
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -2.62 -2.05 -3.72 -7.32 -8.80 -13 -13 11 -10 9.26 -36
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 -31.68 -91.29 11.29 -2.84 2.23 -8.58
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 -37.94 -100.15 -19.38 -4.66 6.49 -2.99
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 -37.94 -100.15 -19.38 -4.66 6.49 -2.99
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.06 0.79 1.32 0.77
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.10 4.38 2.47
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.92 1.98 2.87
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.05 0.41 0.91 0.96
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 88.96 83.30 147.60
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 396.02 184.33 127.27
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 6,720.67 894.09 402.31 381.87
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -6,720.67 -409.11 -134.68 -107.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -0.39 -0.36 -1.50 -1.47 -1.78 -1.27 -0.37 -27 -25 -33 -1.32
Invested Capital Turnover		 0.00 0.00 0.00 0.00 0.00 -0.11 0.00 -0.11 -0.82 -1.64 -2.63
Increase / (Decrease) in Invested Capital		 1.30 0.04 -1.15 0.04 -0.31 0.50 0.91 -26 1.53 -7.47 31
Enterprise Value (EV)		 8.90 8.35 131 103 115 162 93 228 285 147 180
Market Capitalization		 9.85 12 159 126 129 192 114 252 299 173 216
Book Value per Share		 $0.05 $0.26 $1.69 $1.08 $0.60 $1.13 $0.61 ($0.10) ($0.44) ($0.21) $1.26
Tangible Book Value per Share		 $0.05 $0.26 $1.69 $1.08 $0.60 $1.13 $0.61 ($0.10) ($0.44) ($0.21) $1.26
Total Capital		 0.55 3.57 27 21 12 29 16 -2.93 -12 -6.01 35
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.36 -0.29 -0.14 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.36 -0.29 -0.14 0.00
Net Debt		 -0.94 -3.93 -28 -23 -14 -30 -21 -24 -14 -27 -37
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -0.39 -0.36 -1.50 -1.47 -2.04 -1.27 -0.37 -1.66 6.04 11 20
Debt-free Net Working Capital (DFNWC)		 0.55 3.57 27 21 12 29 21 22 19 37 57
Net Working Capital (NWC)		 0.55 3.57 27 21 12 29 21 22 19 37 57
Net Nonoperating Expense (NNE)		 -0.66 0.78 2.18 2.60 3.67 5.59 5.29 7.90 7.11 2.23 5.34
Net Nonoperating Obligations (NNO)		 -0.94 -3.93 -28 -23 -14 -30 -16 -24 -14 -27 -37
Total Depreciation and Amortization (D&A)		 0.00 0.00 0.00 0.00 0.06 0.40 0.02 0.15 0.29 0.16 0.17
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% -749.41% 0.00% -107.82% 28.40% 22.24% 44.21%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 17,100.00% 0.00% 1,440.98% 90.84% 78.26% 126.62%
Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 17,100.00% 0.00% 1,440.98% 90.84% 78.26% 126.62%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.06) ($0.22) ($0.47) $0.00 ($0.64) ($0.76) ($0.67) ($0.90) ($0.60) ($0.02) ($0.34)
Adjusted Weighted Average Basic Shares Outstanding		 10.94M 13.64M 18.46M 0.00 19.90M 26.00M 26.01M 26.28M 26.57M 27.29M 28.58M
Adjusted Diluted Earnings per Share		 ($0.06) ($0.22) ($0.47) $0.00 ($0.64) ($0.76) ($0.67) ($0.90) ($0.60) ($0.02) ($0.34)
Adjusted Weighted Average Diluted Shares Outstanding		 10.94M 13.64M 18.46M 0.00 19.90M 26.00M 26.01M 26.28M 26.57M 27.29M 28.58M
Adjusted Basic & Diluted Earnings per Share		 ($0.06) ($0.22) ($0.47) ($0.52) ($0.64) ($0.76) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 10.83M 12.77M 15.01M 18.94M 19.90M 23.70M 26.01M 26.41M 27.10M 27.59M 34.48M
Normalized Net Operating Profit after Tax (NOPAT)		 -1.32 -2.01 -4.87 -7.29 -9.11 -13 -12 -16 -8.94 1.80 -4.40
Normalized NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% -7,364.41% 0.00% -1,030.12% -42.07% 3.78% -9.85%
Pre Tax Income Margin		 0.00% 0.00% 0.00% 0.00% 0.00% -10,652.35% 0.00% -1,532.90% -75.50% -0.15% -21.58%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 -43.27 -121.54 -24.25 -3.48 0.58 -1.50
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 -30.46 -84.90 -16.97 -2.43 0.43 -1.06
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 -43.27 -121.54 -24.25 -3.48 0.58 -1.50
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 -30.46 -84.90 -16.97 -2.43 0.43 -1.06
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% -0.56% -0.77% -0.24% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Adherex Technologies

This table displays calculated financial ratios and metrics derived from Adherex Technologies' official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 26,419,511.00 26,634,676.00 27,099,908.00 27,322,141.00 27,364,335.00 - 27,594,008.00 27,618,743.00 27,831,698.00 28,116,829.00 34,475,178.00
DEI Adjusted Shares Outstanding		 26,419,511.00 26,634,676.00 27,099,908.00 27,322,141.00 27,364,335.00 - 27,594,008.00 27,618,743.00 27,831,698.00 28,116,829.00 34,475,178.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.07 -0.10 0.47 -0.20 -0.21 - -0.04 -0.11 -0.02 -0.17 0.01
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% 534.20% 1,413.24% 118.41% 7.05% -18.59% -65.52% 32.91% 78.69% 73.84% 72.64%
EBITDA Growth		 87.68% 70.68% 373.89% -10.38% -432.40% 2.01% -105.24% 45.50% 96.51% -167.03% 86.13%
EBIT Growth		 86.87% 69.86% 358.82% -8.47% -400.00% 43.27% -105.81% 46.28% 96.31% -148.25% 83.54%
NOPAT Growth		 87.13% 70.37% 472.54% -7.99% -411.50% 48.62% -104.12% 45.78% 96.37% -173.34% 85.27%
Net Income Growth		 76.92% 60.89% 312.11% -2.00% -207.18% 25.99% -109.08% 43.24% 88.88% -141.11% 117.25%
EPS Growth		 77.42% 65.38% 278.26% 4.76% -200.00% 77.78% -109.76% 45.00% 90.48% -750.00% 125.00%
Operating Cash Flow Growth		 44.91% 28.55% 800.14% -112.54% 20.07% 69.67% -111.06% 56.05% 167.68% -304.48% 155.10%
Free Cash Flow Firm Growth		 339.74% -112.69% 3,050.62% 981.84% -5.71% 343.50% -134.01% -149.33% -202.45% -586.13% -29.22%
Invested Capital Growth		 -819.56% 5.71% -1,892.51% 0.00% -96.82% -29.65% 40.79% 41.15% 41.95% 95.97% 91.27%
Revenue Q/Q Growth		 95.94% 49.42% 160.68% -71.38% -3.97% 13.64% 10.42% 10.30% 29.11% 10.55% 9.66%
EBITDA Q/Q Growth		 78.64% -79.77% 928.76% -134.68% -3.04% 66.91% 16.54% -260.50% 93.40% -1,245.56% 95.66%
EBIT Q/Q Growth		 77.67% -74.06% 855.74% -136.92% -2.95% 80.25% 22.57% -241.21% 92.93% -1,229.17% 94.87%
NOPAT Q/Q Growth		 78.20% -78.76% 1,179.92% -125.67% -3.23% 82.05% 13.49% -238.12% 93.08% -1,250.79% 95.34%
Net Income Q/Q Growth		 65.71% -43.65% 578.64% -143.26% -3.28% 65.39% 41.31% -170.56% 79.76% -650.16% 104.20%
EPS Q/Q Growth		 66.67% -28.57% 555.56% -148.78% -5.00% 90.48% -100.00% -175.00% 81.82% -750.00% 105.88%
Operating Cash Flow Q/Q Growth		 30.06% -76.09% 903.44% -121.48% 73.70% 33.18% -192.94% 14.64% 140.50% -499.33% 139.90%
Free Cash Flow Firm Q/Q Growth		 528.59% -113.99% 2,235.76% -31.16% -54.17% -63.86% -398.33% 0.16% 4.82% -71.49% 20.70%
Invested Capital Q/Q Growth		 0.00% -8.40% -92.37% 7.80% -2.37% 28.59% 12.14% 8.37% -0.98% 95.04% -90.27%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 94.92% 92.96% 97.83% 91.63% 80.54% 91.56% 95.74% 89.98% 94.70% 87.20% 96.23%
EBITDA Margin		 -14.87% -17.89% 56.89% -68.95% -73.97% -21.54% -8.65% -28.27% -1.44% -17.58% -0.70%
Operating Margin		 -15.61% -18.67% 54.16% -69.39% -74.59% -11.79% -9.23% -28.31% -1.52% -18.53% -0.79%
EBIT Margin		 -15.98% -18.61% 53.96% -69.62% -74.63% -12.97% -9.10% -28.14% -1.54% -18.52% -0.87%
Profit (Net Income) Margin		 -28.66% -27.55% 50.59% -76.47% -82.23% -25.05% -13.31% -32.66% -5.12% -34.74% 1.33%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 122.53% 0.00% 100.00% 100.00% 102.27% 0.00%
Interest Burden Percent		 179.35% 148.01% 93.74% 109.83% 110.18% 157.59% 0.00% 116.05% 332.29% 183.39% 0.00%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 523.22% 226.13% -131.51% -201.55% 14.43% 4.98% 1,007.54% 272.95% 143.64% -65.82% -52.68%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 -8.44% -14.70% 53.30% -53.89% -94.50% -17.17% -4.86% -17.35% -1.10% -14.32% -0.75%
Return on Assets (ROA)		 -15.13% -21.76% 49.97% -59.19% -104.12% -33.16% -7.12% -20.13% -3.67% -26.85% 1.15%
Return on Common Equity (ROCE)		 523.22% 226.13% -131.51% -201.55% 14.43% 4.98% 1,007.54% 272.95% 143.64% -65.82% -52.68%
Return on Equity Simple (ROE_SIMPLE)		 192.00% 0.00% 94.36% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -0.71 -1.27 14 -3.53 -3.64 -0.65 -0.57 -1.91 -0.13 -1.79 -0.08
NOPAT Margin		 -10.93% -13.07% 54.16% -48.57% -52.21% -8.25% -6.46% -19.81% -1.06% -12.97% -0.55%
Net Nonoperating Expense Percent (NNEP)		 -12.82% -7.48% -3.89% -9.36% -7.86% -6.60% -1.61% -3.99% -1.62% -9.44% 0.90%
Return On Investment Capital (ROIC_SIMPLE)		 - 10.69% 500.47% 219.91% 67.46% 10.88% 9.42% 25.24% 2.88% -5.04% -0.22%
Cost of Revenue to Revenue		 5.08% 7.04% 2.17% 8.37% 19.46% 8.44% 4.26% 10.02% 5.30% 12.80% 3.77%
SG&A Expenses to Revenue		 58.40% 71.58% 23.14% 94.52% 87.77% 52.95% 67.02% 72.07% 54.18% 61.27% 21.09%
R&D to Revenue		 0.18% 0.33% 0.01% 2.16% 1.39% 0.63% 1.07% 1.11% 0.23% 0.15% 0.32%
Operating Expenses to Revenue		 110.53% 111.64% 43.68% 161.02% 155.13% 103.34% 104.97% 118.29% 96.22% 105.73% 97.01%
Earnings before Interest and Taxes (EBIT)		 -1.04 -1.81 14 -5.06 -5.21 -1.03 -0.80 -2.72 -0.19 -2.55 -0.13
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -0.97 -1.74 14 -5.01 -5.16 -1.71 -0.76 -2.73 -0.18 -2.42 -0.11
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 99.98 0.00 0.00 0.00 0.00 0.00 0.00 6.10 5.63
Price to Tangible Book Value (P/TBV)		 0.00 0.00 99.98 0.00 0.00 0.00 0.00 0.00 0.00 6.10 5.63
Price to Revenue (P/Rev)		 15.20 14.06 6.70 3.41 2.77 3.65 5.44 6.88 6.72 4.85 4.16
Price to Earnings (P/E)		 0.00 0.00 105.96 61.04 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.94% 1.64% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 14.23 13.42 5.56 2.53 1.95 3.08 4.70 6.32 6.15 4.03 3.37
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 34.76 18.40 38.07 57.18 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 40.44 21.37 59.39 60.96 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 40.04 21.07 81.67 81.55 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 9.09 5.37 4.08 5.43 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 21.25 0.00 4.78 2.45 4.07 15.83 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.03 0.02 -0.09 0.18 0.04 0.02 0.02 0.02 0.02 0.00 0.00
Long-Term Debt to Equity		 0.03 0.02 -0.09 0.18 0.04 0.02 0.02 0.02 0.02 0.00 0.00
Financial Leverage		 2.33 2.66 10.76 31.91 3.39 2.31 25.91 7.04 6.48 -2.15 -1.98
Leverage Ratio		 -6.40 -3.79 -21.04 -46.54 -4.96 -4.10 -40.33 -12.25 -11.20 3.90 3.72
Compound Leverage Factor		 -11.47 -5.61 -19.73 -51.12 -5.47 -6.47 0.00 -14.22 -37.20 7.16 0.00
Debt to Total Capital		 2.75% 2.42% -9.76% 15.40% 4.21% 2.31% 2.10% 1.49% 2.18% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 2.75% 2.42% -9.76% 15.40% 4.21% 2.31% 2.10% 1.49% 2.18% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 97.25% 97.58% 109.76% 84.60% 95.79% 97.69% 97.90% 98.51% 97.82% 100.00% 100.00%
Debt to EBITDA		 0.02 0.02 -0.04 -0.04 -0.09 -0.05 0.01 0.01 0.02 0.00 0.00
Net Debt to EBITDA		 0.76 1.08 -7.16 -6.44 -16.03 -10.44 1.93 1.82 4.10 0.00 0.00
Long-Term Debt to EBITDA		 0.02 0.02 -0.04 -0.04 -0.09 -0.05 0.01 0.01 0.02 0.00 0.00
Debt to NOPAT		 0.02 0.03 -0.04 -0.04 -0.19 -0.08 0.02 0.02 0.03 0.00 0.00
Net Debt to NOPAT		 1.06 1.52 -8.24 -7.38 -34.40 -14.89 2.72 2.78 6.75 0.00 0.00
Long-Term Debt to NOPAT		 0.02 0.03 -0.04 -0.04 -0.19 -0.08 0.02 0.02 0.03 0.00 0.00
Altman Z-Score		 -10.45 -5.34 0.87 -1.60 -2.32 -2.82 -3.23 -2.95 -1.82 0.63 0.92
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 4.84 3.56 6.93 8.02 7.80 6.38 5.13 4.85 4.69 6.37 6.98
Quick Ratio		 4.33 2.92 6.25 7.14 7.16 5.71 4.55 4.30 4.21 5.71 6.15
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 20 -2.80 60 41 19 6.81 -20 -20 -19 -33 -26
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 21.54 -2.31 56.69 38.55 18.02 3.88 -33.59 -33.43 -32.29 -14.06 -3,751.47
Operating Cash Flow to Interest Expense		 -2.97 -4.02 37.05 -7.86 -2.11 -0.84 -7.14 -6.07 2.50 -2.53 339.86
Operating Cash Flow Less CapEx to Interest Expense		 -2.97 -4.02 37.05 -7.86 -2.11 -0.84 -7.14 -6.07 2.50 -2.53 339.86
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.53 0.79 0.99 0.77 1.27 1.32 0.53 0.62 0.72 0.77 0.86
Accounts Receivable Turnover		 0.00 4.10 0.00 3.97 5.66 4.38 2.40 2.23 2.41 2.47 2.98
Inventory Turnover		 0.00 0.92 1.15 1.01 2.22 1.98 1.73 1.55 1.48 2.87 2.43
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover		 0.24 0.41 0.42 0.49 0.94 0.91 0.57 0.65 0.55 0.96 0.69
Days Sales Outstanding (DSO)		 0.00 88.96 0.00 91.92 64.47 83.30 151.86 163.39 151.74 147.60 122.42
Days Inventory Outstanding (DIO)		 0.00 396.02 317.51 359.96 164.25 184.33 210.48 235.58 246.30 127.27 150.20
Days Payable Outstanding (DPO)		 1,513.64 894.09 867.89 746.62 388.27 402.31 636.29 563.22 665.52 381.87 532.66
Cash Conversion Cycle (CCC)		 -1,513.64 -409.11 -550.37 -294.74 -159.55 -134.68 -273.95 -164.26 -267.49 -107.00 -260.04
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -23 -25 -48 -45 -46 -33 -29 -26 -27 -1.32 -2.50
Invested Capital Turnover		 -1.01 -0.82 -1.77 -2.19 -1.43 -1.64 -0.80 -0.94 -1.07 -2.63 -3.27
Increase / (Decrease) in Invested Capital		 -21 1.53 -46 -45 -22 -7.47 20 18 19 31 26
Enterprise Value (EV)		 186 285 250 124 96 147 145 210 238 180 172
Market Capitalization		 198 299 301 167 137 173 168 229 261 216 212
Book Value per Share		 ($0.40) ($0.44) $0.11 ($0.05) ($0.19) ($0.21) ($0.21) ($0.27) ($0.16) $1.26 $1.09
Tangible Book Value per Share		 ($0.40) ($0.44) $0.11 ($0.05) ($0.19) ($0.21) ($0.21) ($0.27) ($0.16) $1.26 $1.09
Total Capital		 -11 -12 2.75 -1.60 -5.40 -6.01 -6.01 -7.58 -4.59 35 38
Total Debt		 -0.30 -0.29 -0.27 -0.25 -0.23 -0.14 -0.13 -0.11 -0.10 0.00 0.00
Total Long-Term Debt		 -0.30 -0.29 -0.27 -0.25 -0.23 -0.14 -0.13 -0.11 -0.10 0.00 0.00
Net Debt		 -13 -14 -51 -43 -41 -27 -23 -19 -22 -37 -40
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 2.63 6.04 7.15 11 10 11 12 14 14 20 17
Debt-free Net Working Capital (DFNWC)		 15 19 58 54 51 37 35 32 36 57 57
Net Working Capital (NWC)		 15 19 58 54 51 37 35 32 36 57 57
Net Nonoperating Expense (NNE)		 1.16 1.41 0.91 2.03 2.09 1.33 0.60 1.24 0.51 3.00 -0.28
Net Nonoperating Obligations (NNO)		 -13 -14 -51 -43 -41 -27 -23 -19 -22 -37 -40
Total Depreciation and Amortization (D&A)		 0.07 0.07 0.74 0.05 0.05 -0.68 0.04 -0.01 0.01 0.13 0.03
Debt-free, Cash-free Net Working Capital to Revenue		 20.18% 28.40% 15.91% 23.25% 20.69% 22.24% 38.59% 41.06% 36.87% 44.21% 33.56%
Debt-free Net Working Capital to Revenue		 115.18% 90.84% 129.77% 111.32% 102.40% 78.26% 111.94% 97.23% 93.45% 126.62% 112.34%
Net Working Capital to Revenue		 115.18% 90.84% 129.77% 111.32% 102.40% 78.26% 111.94% 97.23% 93.45% 126.62% 112.34%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.07) ($0.09) $0.41 ($0.20) ($0.21) ($0.02) ($0.04) ($0.11) ($0.02) ($0.17) $0.01
Adjusted Weighted Average Basic Shares Outstanding		 26.60M 26.57M 27.05M 27.30M 27.37M 27.29M 27.58M 27.66M 27.89M 28.58M 34.34M
Adjusted Diluted Earnings per Share		 ($0.07) ($0.09) $0.41 ($0.20) ($0.21) ($0.02) ($0.04) ($0.11) ($0.02) ($0.17) $0.01
Adjusted Weighted Average Diluted Shares Outstanding		 26.60M 26.57M 31.09M 27.30M 27.37M 27.29M 27.58M 27.66M 27.89M 28.58M 35.55M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 26.63M 27.10M 27.32M 27.36M 27.43M 27.59M 27.62M 27.83M 28.12M 34.48M 34.74M
Normalized Net Operating Profit after Tax (NOPAT)		 -0.71 -1.27 9.62 -3.53 -3.64 -0.65 -0.57 -1.91 -0.13 -1.79 -0.08
Normalized NOPAT Margin		 -10.93% -13.07% 37.91% -48.57% -52.21% -8.25% -6.46% -19.81% -1.06% -12.97% -0.55%
Pre Tax Income Margin		 -28.66% -27.55% 50.59% -76.47% -82.23% -20.44% 0.00% -32.66% -5.12% -33.97% 0.00%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -1.12 -1.50 12.99 -4.74 -4.98 -0.58 -1.32 -4.47 -0.32 -1.08 -18.71
NOPAT to Interest Expense		 -0.77 -1.05 13.04 -3.31 -3.48 -0.37 -0.93 -3.15 -0.22 -0.76 -11.90
EBIT Less CapEx to Interest Expense		 -1.12 -1.50 12.99 -4.74 -4.98 -0.58 -1.32 -4.47 -0.32 -1.08 -18.71
NOPAT Less CapEx to Interest Expense		 -0.77 -1.05 13.04 -3.31 -3.48 -0.37 -0.93 -3.15 -0.22 -0.76 -11.90
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

FENNEC Pharmaceuticals (NASDAQ: FENC) showed a sharp turnaround in Q1 2026, with revenue growth and a return to profitability after a weak second half of 2025. However, the company still carries a meaningful debt and liability load, and its earnings remain volatile quarter to quarter.

  • Revenue rebounded in Q1 2026 to $15.1 million, up from $13.8 million in Q4 2025 and $8.8 million in Q1 2025.
  • Gross profit remained strong at $14.5 million in Q1 2026, indicating the company still has solid top-line economics.
  • The company returned to net income in Q1 2026, posting $201,000 in profit versus a $4.8 million loss in Q4 2025.
  • Operating cash flow improved significantly to $2.4 million in Q1 2026, compared with a negative $5.9 million in Q4 2025.
  • Cash and equivalents increased to $40.2 million from $21.9 million at the end of Q3 2025, giving the company a stronger short-term liquidity position.
  • Current assets rose materially to $66.9 million, providing a solid cushion against near-term obligations.
  • Marketing and SG&A spending remained elevated, which helped support revenue but also kept margins tight.
  • Interest income helped offset interest expense, but financing costs still remain an ongoing earnings pressure.
  • Total liabilities were still high at $34.1 million, including $24.6 million in noncurrent liabilities.
  • Retained earnings remained deeply negative at -$229.2 million, reflecting a long history of accumulated losses.

Looking at the longer trend, FENC’s revenue has generally improved from 2024 into 2026, but profitability has not been stable. The company posted a strong profit in Q1 2024, then swung back to losses through much of 2024 and 2025 before recovering in the latest quarter. That pattern suggests the business can be profitable, but it has not yet established consistent earnings power.

The balance sheet also improved versus earlier periods. Cash grew sharply in Q1 2026, and the company’s current assets now exceed current liabilities by a wide margin. That said, the company still has negative retained earnings and a large accumulated equity deficit from prior losses, so investors should not view the balance sheet as risk-free.

From a retail investor perspective, the key takeaway is that Q1 2026 was a step in the right direction: revenue rose, cash flow turned positive, and net income returned to the black. The main question going forward is whether FENC can sustain this momentum without letting operating expenses or financing costs erode the gains.

07/05/26 06:47 AM ETAI Generated. May Contain Errors.

Adherex Technologies Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Adherex Technologies' financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Adherex Technologies' net income appears to be on an upward trend, with a most recent value of -$9.74 million in 2025, rising from -$659 thousand in 2015. The previous period was -$436 thousand in 2024. View Adherex Technologies' forecast to see where analysts expect Adherex Technologies to go next.

Adherex Technologies' total operating income in 2025 was -$6.28 million, based on the following breakdown:
  • Total Gross Profit: $40.88 million
  • Total Operating Expenses: $47.16 million

Over the last 10 years, Adherex Technologies' total revenue changed from $0.00 in 2015 to $44.64 million in 2025, a change of 4,464,200,000.0%.

Adherex Technologies' total liabilities were at $35.08 million at the end of 2025, a 31.0% decrease from 2024, and a 7,347.8% increase since 2015.

In the past 10 years, Adherex Technologies' cash and equivalents has ranged from $942 thousand in 2015 to $36.79 million in 2025, and is currently $36.79 million as of their latest financial filing in 2025.

Over the last 10 years, Adherex Technologies' book value per share changed from 0.05 in 2015 to 1.26 in 2025, a change of 2,418.2%.


Related Companies

Financial statements for NASDAQ:FENC last updated on 7/2/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
From the man who predicted 2008 crash…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel